Dalfen Divests High Point Life Science Building

Dalfen Divests High Point Life Science Building
Dalfen Divests High Point Life Science Building

Starwood Property Trust Acquires High Point Clinical Trial Building for $12.5M

Starwood Property Trust has acquired the 107,408-square-foot High Point Clinical Trial building, located at 4160 Mendenhall Oaks Parkway, for $12.5 million. The property was purchased from Dalfen Industrial and had remained vacant since 2023. Prior to its closure, High Point Clinical Trials reportedly faced several lawsuits.

This marks Starwood’s first investment in the Triad region. The company is one of the largest commercial mortgage special servicing firms in the U.S., with a diverse portfolio valued at approximately $25 billion. Its holdings span commercial and residential lending, infrastructure lending, and investment properties. In addition to this recent acquisition, Starwood already owns multiple industrial properties throughout North Carolina, particularly in Charlotte and Winston-Salem.

Dalfen Industrial, which originally purchased the High Point property in April 2018, continues to hold other industrial assets across North Carolina. The firm specializes in acquiring, developing, and operating last-mile industrial properties in strategic U.S. markets.

This transaction marks a notable shift in the property’s future, potentially signaling new industrial or life sciences use under Starwood’s ownership.

About the Publisher:
Steve Griffin is based in sunny Palm Harbor, Florida. He’s an accountant by profession and the owner of GRIFFIN Tax and REVVED Up Accounting. In addition, Steve founded Madison Avenue Technology. With a strong passion for commercial real estate, he’s also dedicated to keeping you up to date with the latest industry news.

Share the Post:

Related Posts